Enterin CEO and leadership

David has significant “hands on” experience in pharma/biotech with proficiency in the following areas:* Strategic, creative leader with Executive and BOD experience in start-ups to established companies both public and private with over $100M in capital raised* M&A: Led cross functional R&D and Commercial teams in the evaluation of the entire product portfolio leading to the acquisition of Serono Biotech for $13.5B. Honored by Merck Board as a top contributor in closing the deal* M&A: Leader of cross-functional teams including Discovery, Clinical Development, Regulatory, IP and Commercial in the evaluation of over 40 companies ranging in value from $200M-$18B* Licensing: Leader of scientific and business cross-functional team assessment of over 700 cancer targets leading to 40 due diligences and two signed term sheets* Deep understanding of drug development, Regulatory, all Commercial/business functions, IP, Manufacturing and Operations* Global experience in launch preparation of orphan drugs to billion-dollar brands* Expertise at both the strategic and operational level and most enjoy building new businesses from the ground up*P&L responsibility

Professor of Neurology & Former Chief of Neurovascular Division at Weill-Cornell Medical College. Founder, Chair, and CEO of several med-tech and biotech companies. Holder of close to 200 patents. Dr. Barbut was brought up in Istanbul, Turkey. She trained as an internist and subsequently as a neurologist in Great Britain and the USA. She received her bachelor’s degree from University College London and her Medical Degree from University College Hospital. She did her post-graduate training at Imperial College, the Royal Brompton Hospital and the National Hospital for Neurology and Neurosurgery, Queens’ Square. She is a Fellow of the Royal College of Physicians of the United Kingdom. She completed her neurologic training at Weill-Cornell Medical Center- Cornell University Medical College and Memorial Sloan-Kettering Cancer Center. Subsequently she became an Attending Physician at New York Hospital and Professor of Neurology at Cornell University. She was Chief of the Neurovascular Division and of the Stroke Research Program. She left academia in 2000 after founding the second of her 5 companies. Dr. Barbut is sole author or lead author on close to 200 issued or pending patents, mostly relating to methods for neuroprotection, cerebral hypothermia, the treatment of cerebral ischemia, pain, neuromodulation, Parkinson’s disease and other neurodegenerative disorders. She is also the lead or senior author on over 100 peer-reviewed articles and abstracts. She has been involved in founding, funding and running biotech companies for 20 years. She recently co-founded Enterin, where she serves as President and CMO. She is also Board Chair at Novo Therapeutics, Sarentis Therapeutics and Muse and Board member at Israel Brain Technologies.

Nancy has more than 30 years’ experience with finance and accounting and is the Chief Financial Officer for several medical device and pharmaceutical companies, including Enterin. She brings financial and fundraising expertise to over 35 life science start-up companies in the Midwest, New York, and California, along with experience with public companies in Australia and Europe. She earned a BA in Accounting and Business Administration from the University of St. Thomas and holds a Certified Public Accountant license.

Professor of Neurology & Former Chief of Neurovascular Division at Weill-Cornell Medical College. Founder, Chair, and CEO of several med-tech and biotech companies. Holder of close to 200 patents. Dr. Barbut was brought up in Istanbul, Turkey. She trained as an internist and subsequently as a neurologist in Great Britain and the USA. She received her bachelor’s degree from University College London and her Medical Degree from University College Hospital. She did her post-graduate training at Imperial College, the Royal Brompton Hospital and the National Hospital for Neurology and Neurosurgery, Queens’ Square. She is a Fellow of the Royal College of Physicians of the United Kingdom. She completed her neurologic training at Weill-Cornell Medical Center- Cornell University Medical College and Memorial Sloan-Kettering Cancer Center. Subsequently she became an Attending Physician at New York Hospital and Professor of Neurology at Cornell University. She was Chief of the Neurovascular Division and of the Stroke Research Program. She left academia in 2000 after founding the second of her 5 companies. Dr. Barbut is sole author or lead author on close to 200 issued or pending patents, mostly relating to methods for neuroprotection, cerebral hypothermia, the treatment of cerebral ischemia, pain, neuromodulation, Parkinson’s disease and other neurodegenerative disorders. She is also the lead or senior author on over 100 peer-reviewed articles and abstracts. She has been involved in founding, funding and running biotech companies for 20 years. She recently co-founded Enterin, where she serves as President and CMO. She is also Board Chair at Novo Therapeutics, Sarentis Therapeutics and Muse and Board member at Israel Brain Technologies.

David has significant “hands on” experience in pharma/biotech with proficiency in the following areas:* Strategic, creative leader with Executive and BOD experience in start-ups to established companies both public and private with over $100M in capital raised* M&A: Led cross functional R&D and Commercial teams in the evaluation of the entire product portfolio leading to the acquisition of Serono Biotech for $13.5B. Honored by Merck Board as a top contributor in closing the deal* M&A: Leader of cross-functional teams including Discovery, Clinical Development, Regulatory, IP and Commercial in the evaluation of over 40 companies ranging in value from $200M-$18B* Licensing: Leader of scientific and business cross-functional team assessment of over 700 cancer targets leading to 40 due diligences and two signed term sheets* Deep understanding of drug development, Regulatory, all Commercial/business functions, IP, Manufacturing and Operations* Global experience in launch preparation of orphan drugs to billion-dollar brands* Expertise at both the strategic and operational level and most enjoy building new businesses from the ground up*P&L responsibility

Professor of Neurology & Former Chief of Neurovascular Division at Weill-Cornell Medical College. Founder, Chair, and CEO of several med-tech and biotech companies. Holder of close to 200 patents. Dr. Barbut was brought up in Istanbul, Turkey. She trained as an internist and subsequently as a neurologist in Great Britain and the USA. She received her bachelor’s degree from University College London and her Medical Degree from University College Hospital. She did her post-graduate training at Imperial College, the Royal Brompton Hospital and the National Hospital for Neurology and Neurosurgery, Queens’ Square. She is a Fellow of the Royal College of Physicians of the United Kingdom. She completed her neurologic training at Weill-Cornell Medical Center- Cornell University Medical College and Memorial Sloan-Kettering Cancer Center. Subsequently she became an Attending Physician at New York Hospital and Professor of Neurology at Cornell University. She was Chief of the Neurovascular Division and of the Stroke Research Program. She left academia in 2000 after founding the second of her 5 companies. Dr. Barbut is sole author or lead author on close to 200 issued or pending patents, mostly relating to methods for neuroprotection, cerebral hypothermia, the treatment of cerebral ischemia, pain, neuromodulation, Parkinson’s disease and other neurodegenerative disorders. She is also the lead or senior author on over 100 peer-reviewed articles and abstracts. She has been involved in founding, funding and running biotech companies for 20 years. She recently co-founded Enterin, where she serves as President and CMO. She is also Board Chair at Novo Therapeutics, Sarentis Therapeutics and Muse and Board member at Israel Brain Technologies.